Accéder au contenu
Merck

HIV-1 infection of human macrophages directly induces viperin which inhibits viral production.

Blood (2012-06-09)
Najla Nasr, Susan Maddocks, Stuart G Turville, Andrew N Harman, Natalie Woolger, Karla J Helbig, John Wilkinson, Chris R Bye, Thomas K Wright, Dharshini Rambukwelle, Heather Donaghy, Michael R Beard, Anthony L Cunningham
RÉSUMÉ

Macrophages are key target cells for HIV-1. HIV-1(BaL) induced a subset of interferon-stimulated genes in monocyte-derived macrophages (MDMs), which differed from that in monocyte-derived dendritic cells and CD4 T cells, without inducing any interferons. Inhibition of type I interferon induction was mediated by HIV-1 inhibition of interferon-regulated factor (IRF3) nuclear translocation. In MDMs, viperin was the most up-regulated interferon-stimulated genes, and it significantly inhibited HIV-1 production. HIV-1 infection disrupted lipid rafts via viperin induction and redistributed viperin to CD81 compartments, the site of HIV-1 egress by budding in MDMs. Exogenous farnesol, which enhances membrane protein prenylation, reversed viperin-mediated inhibition of HIV-1 production. Mutagenesis analysis in transfected cell lines showed that the internal S-adenosyl methionine domains of viperin were essential for its antiviral activity. Thus viperin may contribute to persistent noncytopathic HIV-1 infection of macrophages and possibly to biologic differences with HIV-1-infected T cells.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Farnesol, 95%
Sigma-Aldrich
Farnesol, mixture of isomers, ≥95%, stabilized, FG